Condition: Hemophilia · Sponsor: Jiangsu BioJeTay Biotechnology Co., Ltd.
This study will assess the efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitor
This description comes directly from the study's public registry record.
Yanli Wang · 010-67519614 · wangyanli@staidson.com
Always discuss trial participation with your own doctor first.
| Anhui Provincial Hospital | Hefei, Anhui, China | Not Yet Recruiting |
| Lanzhou University First Hospital | Lanzhou, Gansu, China | Recruiting |
| Nanfang Hospital, Southern Medical University | Guangzhou, Guangdong, China | Recruiting |
| Shenzhen Second People's Hospital | Shenzhen, Guangdong, China | Recruiting |
| The First affiliated hospital of Guangxi Medical University | Nanning, Guangxi, China | Recruiting |
| North China University of Science and Technology Affiliated Hospital | Tangshan, Hebei, China | Recruiting |
| Harbin First Hospital Hematology Tumor Research Center | Harbin, Heilongjiang, China | Recruiting |
| Henan Cancer Hospital | Zhengzhou, Henan, China | Recruiting |
| Huazhong University of Science and Technology Union Hospital | Wuhan, Hubei, China | Not Yet Recruiting |
| Jiangsu Provincial Hospital | Nanjing, Jiangsu, China | Recruiting |
| The First Affiliated Hospital of Nanchang University | Nanchang, Jiangxi, China | Recruiting |
| Jinan Central Clinical College of Shandong First Medical University | Jinan, Shandong, China | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06922045